Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Biochimica Et Biophysica Acta. Proteins and Proteomics
|
December 17, 2018
A comprehensive analysis of the protein-ligand interactions in crystal structures of Mycobacterium tuberculosis EthR
Abdalkarim Tanina, Alexandre Wohlkönig, Sameh H Soror, et al.
ACS Chemical Biology
|
March 18, 2017
Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays
Petar O Nikiforov, Michal Blaszczyk, Sachin Surade, et al.
Biorxiv : the Preprint Server for Biology
|
October 3, 2025
Pyrazinamide kills <i>Mycobacterium tuberculosis</i> via pH-driven weak-acid permeation and cytosolic acidification
Janïs Laudouze, Tatyana I Rokitskaya, Akira Abolet, et al.
ACS Infectious Diseases
|
February 4, 2020
Fragment-Based Optimized EthR Inhibitors with <i>in Vivo</i> Ethionamide Boosting Activity
Baptiste Villemagne, Arnaud Machelart, Ngoc Chau Tran, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 2023
Loss-of-function mutations in <i>ndh</i> do not confer delamanid, ethionamide, isoniazid, or pretomanid resistance in <i>Mycobacterium tuberculosis</i>
Sushil Pandey, Catherine Vilchèze, Jim Werngren, et al.
The Journal of Biological Chemistry
|
October 16, 2003
Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis
Benjawan Phetsuksiri, Mary Jackson, Hataichanok Scherman, et al.
The Journal of Biological Chemistry
|
April 5, 2000
Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis
L Kremer, J D Douglas, A R Baulard, et al.
European Journal of Medicinal Chemistry
|
February 21, 2019
A fragment-based approach towards the discovery of N-substituted tropinones as inhibitors of Mycobacterium tuberculosis transcriptional regulator EthR2
Hugues Prevet, Martin Moune, Abdalkarim Tanina, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 29, 2023
Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification
Léo Faïon, Kamel Djaout, Catalin Pintiala, et al.
Journal of Medicinal Chemistry
|
December 29, 2023
Both Nitro Groups Are Essential for High Antitubercular Activity of 3,5-Dinitrobenzylsulfanyl Tetrazoles and 1,3,4-Oxadiazoles through the Deazaflavin-Dependent Nitroreductase Activation Pathway
Galina Karabanovich, Viktória Fabiánová, Anthony Vocat, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Biochimica Et Biophysica Acta. Proteins and Proteomics
|
December 17, 2018
A comprehensive analysis of the protein-ligand interactions in crystal structures of Mycobacterium tuberculosis EthR
Abdalkarim Tanina, Alexandre Wohlkönig, Sameh H Soror, et al.
ACS Chemical Biology
|
March 18, 2017
Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays
Petar O Nikiforov, Michal Blaszczyk, Sachin Surade, et al.
Biorxiv : the Preprint Server for Biology
|
October 3, 2025
Pyrazinamide kills <i>Mycobacterium tuberculosis</i> via pH-driven weak-acid permeation and cytosolic acidification
Janïs Laudouze, Tatyana I Rokitskaya, Akira Abolet, et al.
ACS Infectious Diseases
|
February 4, 2020
Fragment-Based Optimized EthR Inhibitors with <i>in Vivo</i> Ethionamide Boosting Activity
Baptiste Villemagne, Arnaud Machelart, Ngoc Chau Tran, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 2023
Loss-of-function mutations in <i>ndh</i> do not confer delamanid, ethionamide, isoniazid, or pretomanid resistance in <i>Mycobacterium tuberculosis</i>
Sushil Pandey, Catherine Vilchèze, Jim Werngren, et al.
The Journal of Biological Chemistry
|
October 16, 2003
Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis
Benjawan Phetsuksiri, Mary Jackson, Hataichanok Scherman, et al.
The Journal of Biological Chemistry
|
April 5, 2000
Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis
L Kremer, J D Douglas, A R Baulard, et al.
European Journal of Medicinal Chemistry
|
February 21, 2019
A fragment-based approach towards the discovery of N-substituted tropinones as inhibitors of Mycobacterium tuberculosis transcriptional regulator EthR2
Hugues Prevet, Martin Moune, Abdalkarim Tanina, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 29, 2023
Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification
Léo Faïon, Kamel Djaout, Catalin Pintiala, et al.
Journal of Medicinal Chemistry
|
December 29, 2023
Both Nitro Groups Are Essential for High Antitubercular Activity of 3,5-Dinitrobenzylsulfanyl Tetrazoles and 1,3,4-Oxadiazoles through the Deazaflavin-Dependent Nitroreductase Activation Pathway
Galina Karabanovich, Viktória Fabiánová, Anthony Vocat, et al.
Page
of 6